The stock recently tumbled from around 2.40 to nearly 1.30 on a weak earnings outlook. They cited the earnings outlook on weaker demand for their film-based mammography products in light of strength in the interest of digital mammography products.
Interestingly enough, two days later, the company put out a press release introducing their own digital product line. I believe this was a pretty smart move on their part, and should calm the market that they are not going to roll over and play dead as competitors move into more advanced markets.
I would also encourage everyone to read this series of posts on the ICAD message boards regarding a conversation one poster had with IR. It came across to me as very honest, thorough, and certainly gave me some perspective on their business and the market reaction to their outlook.
The stock surged on a rally into the $1.60s on friday before giving back some gains. This shows me the bears are really losing steam on this one after such a steep decline. Although the stock seemed to have been trending down prior to the major drop, I do not think this kind of level can be sustained for very long and am looking for a return to the $1.80-$2.00 on a recovery.
I purchased 350 shares * $1.48 Friday afternoon, and certainly have not been compensated by ICAD for coverage of their stock.
Regards and Best of Luck,
Tim / PQL Research
Posts: 0 | Registered: A Long Time Ago!
| IP: Logged |